Avid Bioservices Inc (CDMO)

[RRdog]

In recent messages I have tried to address some of the reasons why PPHM is valued so poorly if bavi is such a great drug candidate. Most of those reasons have nothing to do with the clinical trials and bavi.

Before listing 22 reasons off the top of my head for PPHMs' low valuation I stated that in spite of these conditions I was a "rabid bull" on this stock. Taking the bullish side of the argument today I note the following:

1. Reason number 8, the NASD delist warning burns off today.
2. Most of the other negatives burn off if the company partners
and bolsters its' balance sheet.
3. The longer the MOS in 2nd line NSCLC extends in time the
better the possibility at the FDA in general, for AA, for
partnering.
4. I stand by my original predictions on 2nd line NSCLC MOS that:
a. MOS is likely to be between 13 and 17 months.
b. That the MOS to Control Arm ratio is likely to exceed
"2.4"
c. That the MOS in 2nd line will be historic in that it will
exceed MOS in all 1st line testing for NCSLC.

Best Regards,
RRdog